BCRX

BioCryst Pharmaceuticals, Inc. News Headlines

$11.33
*  
0.34
3.09%
Get BCRX Alerts
*Delayed - data as of Jan. 26, 2015  -  Find a broker to begin trading BCRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BCRX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
BioCryst Pharma Says FDA Grants Fast Track Designation For BCX4161 - Quick Facts
1/26/2015 7:12:00 AM - RTT News


Strength Seen in Egalet (EGLT): Stock Soars 23.9% - Tale of the Tape
1/23/2015 9:25:00 AM - Zacks.com


UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog
1/22/2015 7:00:00 PM - Zacks.com


UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog
1/22/2015 7:00:00 AM - Investopedia


Flamel Technologies (FLML) in Focus: Stock Gains 15.4% - Tale of the Tape
1/19/2015 9:25:00 AM - Zacks.com


BioCryst's BCX4161 Recommended for Orphan Drug in EU - Analyst Blog
1/15/2015 2:00:00 PM - Investopedia


BioCryst's BCX4161 Recommended for Orphan Drug in EU - Analyst Blog
1/15/2015 2:00:00 PM - Zacks.com


BioCryst Shares Up After Positive Opinion On BCX4161 By EMA
1/14/2015 9:15:00 AM - RTT News


Pharmacyclics (PCYC) Looks Good: Stock Moves 16.4% Up - Tale of the Tape
1/14/2015 8:51:00 AM - Zacks.com


BioCryst Pharma Receives Positive Opinion From EU For Angiodema Compound BCX4161
1/14/2015 7:34:00 AM - RTT News


BioCryst Pharma Appoints Lynne Powell As Chief Commercial Officer - Quick Facts
1/5/2015 7:44:00 AM - RTT News


BioCryst Rises on Positive Ebola Candidate Results - Analyst Blog
12/26/2014 3:00:00 PM - Zacks.com


BioCryst Rises on Positive Ebola Candidate Results - Analyst Blog
12/26/2014 3:00:00 AM - Investopedia


Health Care Sector Update for 12/24/2014: BCRX,ACHN,BLRX,NVS
12/24/2014 12:15:39 PM - MT Newswires


BLRX Does A Deal, CRMD Enters Arabia, IG Exceeds Goal, See What's New In GRANIX
12/23/2014 11:36:00 PM - RTT News


BioCryst Pharma Says FDA Approves RAPIVAB In Acute Uncomplicated Influenza
12/22/2014 4:45:00 AM - RTT News


Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
12/19/2014 10:53:00 AM - Seeking Alpha


The FDA May Find Some Use For Rapivab And Approve The Influenza Antiviral
12/18/2014 1:10:00 PM - Seeking Alpha


Cramer's Lightning Round - Why Did They Fire The Nice Man At Sanofi? (12/17/14)
12/18/2014 6:08:00 AM - Seeking Alpha


Brinson Patrick's Christopher S. James: All Catalysts Are Not Created Equal
12/5/2014 8:55:00 AM - Seeking Alpha


Biocryst Pharm. To Present At  Piper Jaffray Conference ; Webcast At 8:30 AM ET
12/3/2014 7:33:00 AM - RTT News


5 Stocks to Watch Closely for the Rest of 2014
12/1/2014 11:02:16 AM - InvestorPlace Media


2nd Half Of 2014 Biotechnology Catalysts: Part 5
12/1/2014 9:59:00 AM - Seeking Alpha


Use Options For a Chance To Buy BCRX at a 59% Discount
11/25/2014 11:54:05 AM - BNK Invest


Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak
11/13/2014 4:24:00 PM - Seeking Alpha